IOBT FY 2024 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$849,000

Operating Income

-$95M

Net Income

-$95M

EPS (Diluted)

$-1.45

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$82M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$68M

Total Liabilities

$21M

Stockholders' Equity

$47M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$849,000	-$756,000	-12.3%
Operating Income	-$95M	-$91M	-4.1%
Net Income	-$95M	-$86M	-10.9%